Spotlight
Clinical
Blog
Partners
Subscribe
CE
- Therapeutic Cataract & Refractive
- Lens Technology
- Glasses
- Ptosis
- AMD
- COVID-19
- DME
- Ocular Surface Disease
- Optic Relief
- Geographic Atrophy
- Cornea
- Conjunctivitis
- LASIK
- Myopia
- Presbyopia
- Allergy
- Nutrition
- Pediatrics
- Retina
- Cataract
- Contact Lenses
- Lid and Lash
- Dry Eye
- Glaucoma
- Refractive Surgery
- Comanagement
- Blepharitis
- OCT
- Patient Care
- Diabetic Eye Disease
- Technology
Florida bill advances
Last week, the Florida Senate voted 10-3 to approve SB 278, a bill which would grant additional prescribing authority to optometrists.
Tallahassee, FL-Last week, the Florida Senate voted 10-3 to approve SB 278, a bill which would grant additional prescribing authority to optometrists.
The bill grants optometrists the ability to prescribe oral medications. The language of SB 278 states: “requiring a certified optometrist to complete a course and examination on general and ocular pharmaceutical agents before administering or prescribing oral ocular pharmaceutical agents.”
The bill has moved to the Appropriations Committee.
A similar bill, HB 239, is in the Florida House Health & Human Services Committee.
Related Videos
Related Content
